Abilify Maintena 400 mg

Abilify Maintena 400 mg is a medicine authorised by Swissmedic under authorisation number 65774. The authorisation holder is Lundbeck (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 15 March 2016 and the authorisation is valid without a time limit. ATC code N05AX12 places the medicine in the group Psycholeptics.

  • Dispensing category B
  • Authorisation number 65774
  • ATC N05AX12
  • Synthetic medicines
Authorisation data
Authorisation number65774
NameAbilify Maintena 400 mg
Full nameAbilify Maintena 400 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension in einer Fertigspritze
Authorisation holderLundbeck (Schweiz) AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN05AX12
First authorisation15 March 2016
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Abilify Maintena 400 mg, Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension in einer FertigspritzeB15 March 2016

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Fertigspritze(n)N05AX1201.05.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Abilify Maintena 400 mg authorised in Switzerland?

Yes. Abilify Maintena 400 mg is authorised by Swissmedic under authorisation number 65774, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Abilify Maintena 400 mg have?

Abilify Maintena 400 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Abilify Maintena 400 mg?

The authorisation holder is Lundbeck (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com